KURA – kura oncology, inc. (US:NASDAQ)
Stock Stats
News
Kura Oncology (NASDAQ:KURA) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Kura Oncology: A Cautious Buy [Seeking Alpha]
Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI®) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia [Yahoo! Finance]
Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI®) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia
Kura Oncology: Expect Volatility Following Ziftomenib Phase 1b Data [Seeking Alpha]
Form 8-K Kura Oncology, Inc. For: Dec 02
Form 144 Kura Oncology, Inc. Filed by: Leoni Mollie
Form 4 Kura Oncology, Inc. For: Nov 13 Filed by: FORD KATHLEEN
Form 144 Kura Oncology, Inc. Filed by: FORD KATHLEEN
Form 144 Kura Oncology, Inc. Filed by: Powl Brian T.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.